home > news > in the news
TriOptima in the news

  • 01 Aug 2011 Financial News Politics has not stopped sovereign CDS appetite
    • There is no doubt about what the predominating influence on the credit default swap market is at the moment – if not, indeed, on the entire capital market. “It’s the sovereigns that are leading the rest of the market,” said a CDS broker recently. [SUBSCRIPTION]
      read full article
  • 21 Jul 2011 ISDA ISDA Marks First Anniversary of Dodd-Frank Act: Clearing, Transparency Drive Improvements in OTC Derivatives Markets
    • At the first anniversary of the Dodd-Frank Act, market participants, policymakers and others are assessing the safety of the over-the-counter (OTC) derivatives markets in light of the legislation as well as efforts the industry has undertaken over the past few years in conjunction with global regulators.
      read full article
  • 17 Jan 2011 Financial Times It's transparency but not as we know it
    • There is a widely-held belief that the over-thecounter (OTC) derivatives market and the pricing of transactions is too opaque and not accessible to the general public. Real time reporting and price transparency are viewed as the panacea to solve these problems.
      download
  • 01 Sep 2010 Global Investor Operational and credit risk in the bilateral margining process
    • Buy side market participants have developed an intense interest in the OTC derivatives bilateral margining process as a way to control operational and credit risk.
      download
  • 01 Sep 2010 Asia Risk Asian banks in OTC derivatives reconciliation following ISDA initiative
    • Asian banks are starting to adopt over-the-counter derivatives reconciliation systems, following efforts started back in January by the International Swaps and Derivatives Association to create an ‘Asia- Pacific portfolio reconciliation memorandum of understanding’.
      download
  • 01 Oct 2009 Asia Risk Technology Company of the Year
    • Credit risk has shown its dark side as the proverbial Achilles’ heel of the financial system. Faced with extreme illiquidity and a lack of transparency, managing and – where possible – reducing the exposures has been a major challenge for most business heads and risk managers.
      download
  • 01 Sep 2009 Global Investor Improving the collateral management process
    • Following the Lehman bankruptcy in the fall of 2008, many buy-side firms found that loose collateral management policies for their OTC derivatives portfolios left them as unsecured creditors trying to reclaim their funds.
      download
  • 22 Jun 2009 DerivSource Proactive portfolio reconciliation can transform OTC derivatives margining
    • The Collateral Framework Group, an adhoc group of industry professionals, recognized the opportunity and need to automate portfolio reconciliation for risk management purposes long before this function was branded as problematic.
      download
  • 01 Jun 2009 Global Investment Technology With dealers onboard, TriOptima targets buy side
    • With valuation of derivatives gaining more attention over the past year, investors in these securities needed more sophisticated ways to resolve disputes in portfolios or margin calls.
      download
  • 01 May 2009 Credit Back to basics - Multilateral terminations
    • We take you back to the credit basics to review everything you thought you already knew but were too afraid to ask.
      download
  • 01 May 2009 Credit Proactive approach - Reducing counterparty risk and eliminating the confirmation backlog
    • The latest letters to the New York Fed underscore how rapidly market practice standards have changed for OTC derivatives. Volatile markets, bankruptcies, takeovers and bailouts have demonstrated how vital it is to always know where counterparty credit exposure lies.
      download
  • 23 Jan 2008 Structured Credit Investor Gaining momentum
    • OTC derivatives trading volumes continue their extraordinary growth across asset classes. The escalating volumes, complexity of structures and increasing number of counterparties have presented new and urgent challenges to operations as well as counterparty risk management.
      download
Please enter your full name.

Disclaimer
Interest Rate Trade Reporting Repository
Terms and Conditions for Access and Use


1. Scope of Agreement
These terms and conditions (this "Agreement") govern your access to and use of any public repository reports of OTC interest rate derivatives (each a "Report") produced by TriOptima AB ("TriOptima"), as described on the information web page regarding the repository. You must accept this Agreement to access and use Reports. You accept the Agreement by clicking the "I Agree" button on the bottom of this page. TriOptima may at any time, without advance or specific notice, amend this Agreement. Hence, you are expected to review and accept this Agreement each time you wish to access any Report through this website.

2. Intellectual property rights, license to use
You acknowledge that TriOptima is the sole and exclusive owner of any and all intellectual property rights to the structure and layout of any Report.

TriOptima hereby grants to you a non-exclusive license to use Reports in accordance with this Agreement.

3. Prohibited use of Reports
You must not use any Report or the information contained in any Report in a manner that may harm or be detrimental to TriOptima, including without limitation, to use any Report to directly or indirectly compete or promote competition with TriOptima.

You are not allowed to use TriOptima's name or any trademarks, trade names or service marks contained in any Report or this website in advertising, publicity or otherwise; neither are you allowed to copy any marks, specific characteristics or attributes of any Report for any other purpose than for making a lawful and contractually permitted copy of a Report.

4. Non-reliance, no warranty, disclaimer
Each Report is provided to you free of charge. However, TriOptima does not warrant or undertake to make any Reports available to you; hence you acknowledge that TriOptima, in its sole discretion, may or may not make Reports available to you via this website or otherwise.

Each Report is intended for information purposes only. Any information in a Report may at any time be superseded or replaced by new or updated information. Furthermore, the information contained in a Report is based on the information submitted by third parties for the purpose of inclusion in such Report. The information contained in a Report is neither checked, nor verified by TriOptima. Consequently, you acknowledge that Reports are for information purposes only, that they may not be relied upon for any purpose whatsoever, and that they are dependent upon, as regards their accuracy and completeness, the data submitted to TriOptima by third parties.

The parties acknowledge that TriOptima makes no representation or warranty with respect to any Report or this website or any data or materials retrieved, obtained, provided or transmitted, by or to you, using this website. Each Report and this website and all such data and materials are being provided to you "as is". TriOptima hereby disclaims any and all representations and warranties, whether express or implied, including without limitation, any representation or warranty as to merchantability or fitness for a particular purpose, any representations or warranties arising from course of dealing or course of performance, and any representations or warranties of accuracy, reliability or functionality.

To the maximum extent permitted by law, TriOptima disclaims all liability arising out of or in connection with the use of any Report or this website.

Without prejudice to the above, TriOptima shall not be liable to you, or anyone claiming under or through you, for loss of profit, or any indirect or consequential loss or damages under or in connection with this Agreement, the use of any Report or this website, including without limitation, damages for loss of capital, interest, revenue, data or use, or interruption of business, even if you had been advised of the possibility of such damages.

Notwithstanding anything to the contrary in this Agreement, TriOptima does not exclude or limit its liability for wilful misconduct, fraud or death or personal injury arising from TriOptima's negligence.

For purposes of this clause, references to TriOptima shall be deemed to include its affiliates and their respective partners, officers, employees, directors, agents, contractors, representatives, successors and assigns.

5. Viruses, malware
To the best of TriOptima's knowledge, Reports published on this website, this website and the server on which it resides are free from viruses and other malware. However, TriOptima cannot warrant this to be the case, and it is your responsibility to take precautions to prevent your computer and/or network to be affected by viruses or other malware. Hence, TriOptima does not assume any liability for any damage or loss, whether direct or indirect, including loss of data, caused to you by viruses or other malware from Reports published on this website, this website or the server on which it resides, including when you download any Report.

6. Applicable law, disputes
This Agreement and any non-contractual obligations arising in connection with it shall be governed by English law, without regard to its principles of conflicting laws. Each party submits to the exclusive jurisdiction of the English courts for all purposes relating to this Agreement (including the enforcement of any determinations).
I agree    I decline